Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Vassiliki Kotoula"'
Autor:
Foteinos-Ioannis Dimitrakopoulos, Kyriaki Papadopoulou, Dimitrios Pectasides, Anna Batistatou, Kitty Pavlakis, George Fountzilas, Helen P. Kourea, Sofia Chrisafi, George Pentheroudakis, Vassiliki Kotoula, Pavlos Papakostas, Eleni Galani, Eleni Res, Dimitrios Bafaloukos, Angelos Koutras, Georgia-Angeliki Koliou, Mattheos Bobos, Kyriakos Chatzopoulos, Anthoula Asimaki-Vlachopoulou
Publikováno v:
Cancer Research and Treatment. 54:1053-1064
Purpose Angiogenesis is a crucial phenomenon in the development and progression of breast cancer (BC), but the clinical significance of angiogenesis-related proteins in metastatic BC remains unknown. This study investigates the prognostic value of va
Autor:
Aris I. Giotakis, Christos Perisanidis, Christos K. Kontos, Vassiliki Kotoula, Maria Vassilakopoulou, Amanda Psyrri, David L. Rimm, Kyriakos Chatzopoulos, Clarence T. Sasaki, Vamsidhar Velcheti, Theodore Rampias, George Fountzilas, Margaritis Avgeris, Andreas Scorilas
Publikováno v:
Clinical Cancer Research. 22:704-713
Purpose: Programmed death-ligand 1 (PD-L1; also known as CD274 or B7-H1) expression represents a mechanism of immune escape for cancer. Our purpose was to characterize tumor PD-L1 expression and associated T-cell infiltration in primary laryngeal squ
Autor:
Georgia-Angeliki Koliou, George Pentheroudakis, Kalliopi Petraki, Evangelia Razis, Eleftheria Tsolaki, Angelos Koutras, George Kouvatseas, Dimitrios Bafaloukos, Georgios Lazaridis, Vassiliki Kotoula, Anna Batistatou, Kyriaki Papadopoulou, Stavroula Pervana, Dimitrios Pectasides, Haralambos P. Kalofonos, Pavlos Papakostas, George Fountzilas, Sofia Chrisafi, Amanda Psyrri, Konstantine T. Kalogeras, Mattheos Bobos, Christos Christodoulou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0207707 (2018)
PLoS ONE, Vol 13, Iss 12, p e0207707 (2018)
In the current study, we performed a complete analysis, with four different methods, of all four HER family receptors, in a series of patients with metastatic breast cancer treated with trastuzumab-based regimens and evaluated their prognostic value.
Autor:
Sotiris Barbanis, George Karkavelas, Vassiliki Kotoula, Angeliki Cheva, Constantine S. Papadimitriou
Publikováno v:
Acta Neuropathologica. 111:569-578
Accumulating data about the impact of hTERT in astrocytic tumor carcinogenesis and recent evidence about its association with disease outcome prompt the evaluation of this molecule with methods applicable in routine pathology practice. In this study,
Autor:
Dimitrios, Krikelis, Vassiliki, Kotoula, Mattheos, Bobos, Elena, Fountzilas, Konstantinos, Markou, Ilias, Karasmanis, Nikolaos, Angouridakis, Konstantinos, Vlachtsis, Konstantine T, Kalogeras, Angelos, Nikolaou, George, Fountzilas
Publikováno v:
Anticancer research. 34(11)
There exist substantial evidence that laryngeal cancer represents a unique entity among squamous head and neck carcinomas.Tumors from 289 patients with squamous cell laryngeal cancer were assessed for protein (immunohistochemistry) and mRNA (qRT-PCR)
Autor:
Vassiliki Kotoula, Prodromos Hytiroglou, Sophia Kouidou, Vassiliki Kaloutsi, Constantine S. Papadimitriou, Sotiris Barbanis
Publikováno v:
Leukemia & Lymphoma. 43:393-399
We investigated mismatch repair (MMR) gene expression in 31 lymphoid tissue specimens and bone marrow aspirates with malignant lymphoproliferative disorders of B-cell origin (25 cases of lymphoma and six cases of plasma cell myeloma). A multiplex RT-
Autor:
George Fountzilas, Larisa V. Debelenko, Sofia Chrisafi, Vassiliki Kotoula, Eleftheria Tsolaki, Amanda Psyrri, Kyriaki Papadopoulou, Paris Kosmidis, Catherine Michail-Strantzia, Maria Vassilakopoulou, George Lazaridis, Ioannis Efstratiou, Mattheos Bobos
Publikováno v:
Scopus-Elsevier
Anaplastic lymphoma kinase (ALK) break-apart fluorescent in situ hybridization (FISH) is currently used in diagnostics for the selection of non-small cell lung cancer (NSCLC) patients to receive crizotinib. We evaluated ALK status in NSCLC with a nov
Autor:
George Pentheroudakis, Amanda Psyrri, Taiwo A. Togun, Jennifer Bordeaux, George Fountzilas, Veronique Neumeister, Huan Cheng, David L. Rimm, Maria Vassilakopoulou, Urania Dafni, Dimosthenis Skarlos, Mattheos Bobos, Vassiliki Kotoula, Dimitrios Pectasides
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e99131 (2014)
PLoS ONE, Vol 9, Iss 6, p e99131 (2014)
Background We sought to determine the predictive value of in situ mRNA measurement compared to traditional methods on a cohort of trastuzumab-treated metastatic breast cancer patients. Methods A tissue microarray composed of 149, classified as HER2-p
Autor:
George Pentheroudakis, George Fountzilas, George Kouvatseas, Meletios A. Dimopoulos, Dimitrios Pectasides, Flora Zagouri, Dimitrios Dionysopoulos, Epaminontas Samantas, Konstantinos Papazisis, Vassiliki Kotoula, Christos Papandreou, Elpida Charalambous, Angelos Koutras
Publikováno v:
Clinical breast cancer. 14(5)
Background The prognostic utility of vascular endothelial growth factor A (VEGF-A) splice variants in patients with advanced breast cancer treated with bevacizumab has not been studied. Patients and Methods A total of 111 patients with metastatic bre
Autor:
George Kouvatseas, Dimitrios Bafaloukos, Dimosthenis Skarlos, George Fountzilas, Mattheos Bobos, Vassiliki Kotoula, Christos Papadimitriou, George Pentheroudakis, Xanthipi Mavropoulou, Eleni Timotheadou, Angelos Koutras, Dimitrios Pectasides, Eleni Vrettou, Evangelia Razis, Epaminontas Samantas, Georgia Raptou
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 7, p e69256 (2013)
PLoS ONE, Vol 8, Iss 7, p e69256 (2013)
To explore the activity and safety of two schedules of ixabepilone, as first line chemotherapy, in patients with metastatic breast cancer previously treated with adjuvant chemotherapy, a randomized non-comparative phase II study was conducted. From N